Name: Pet Biotics Market By Type (Probiotics, Prebiotics, and Postbiotics), Application (Dry, Wet, Supplements, and Snacks & Treats), Pet (Dogs, Cats, and Other Pets), Form, Function, Manufacturing Technology, and Region – Global Forecast to 2030
Brand: MarketsandMarkets
SKU: FB9544
Price: 4950 USD
Availability: InStock

報告摘要

The pet biotics market is estimated to be worth USD 878.1 million in 2025 and is projected to reach USD 1,232.5 million by 2030, at a CAGR of 7.0%. The global pet biotics market is experiencing significant growth, driven by the rising humanization of pets, which is increasing demand for advanced gut-health ingredients as owners seek microbiome-supporting solutions similar to those used in human nutrition. Additionally, there is a growing focus on preventive health, including immunity, stress reduction, digestion, and overall health performance, which is accelerating the use of functional biotics such as probiotics, prebiotics, and postbiotics, in pet food, supplements, treats & snacks. Furthermore, premiumization trends and the shift toward natural, clean-label, and scientifically backed formulations create strong opportunities for high-quality, clinically validated biotic strains. Additionally, the surge in individualized and condition-specific nutrition opens the door for targeted biotics addressing sensitivities, age-related issues, and breed-specific needs. However, supply chain complexity for high-quality strains, regulatory inconsistencies across regions, and the need for strong scientific substantiation to build consumer trust are expected to pose challenges in the pet biotics market. Furthermore, ensuring the stability and survivability of biotics in various pet food matrices also remains a technical challenge. Overall, increasing wellness awareness and demand for microbiome-focused nutrition present substantial growth opportunities for pet biotics manufacturers to gain a significant share in the market. “Probiotic type is expected to hold a dominant market share during the forecast period” The probiotic types in the pet biotic segments dominate the market due to strong consumer demand for functional nutrition that supports digestive health, immunity, and overall well-being in pets. Scientific evidence demonstrates that probiotic strains, such as Lactobacillus, Bifidobacterium, Bacillus, and Saccharomyces cerevisiae, provide measurable gut and immune benefits, which allows pet food brands to make compelling health claims. Technological advances, such as microencapsulation and strain-specific formulation, help maintain probiotic viability during processing and storage, while ongoing patent activity and product innovation indicate a high commercial value. Despite challenges like strain sensitivity, viability loss during processing, and limited long-term studies, the combination of proven health benefits, consumer awareness, and industry investment has made probiotics a preferred ingredient in dry food, wet food, treats, and supplements. “Dog segment is expected to hold a strong market share among the pet types in the pet biotics market” Dogs are expected to dominate the pet type segment in the pet biotics market. This trend is primarily driven by the increasing humanization of pets, where pet owners are more inclined to treat their dogs as family members and invest in their overall health and wellness. Dogs often suffer from common health issues such as joint pain, digestive problems, and skin allergies, which can be managed through targeted nutritional supplements. As a result, the demand for probiotics & prebiotics tailored specifically for dogs, such as those supporting joint health, coat shine, and immune function, is witnessing significant growth. “North America is expected to dominate the global pet biotics market during the forecast period” North America dominates the pet biotics market due to a combination of high pet ownership, strong consumer spending on pet health, and advanced industry infrastructure. With high awareness among pet owners in the region of functional nutrition, the demand for probiotics, prebiotics, and postbiotics is strong, as these products can promote gut health, immunity, and overall wellness. The region also has a well-established pet food industry that utilizes advanced manufacturing technologies to maintain the viability of sensitive biotic ingredients. Additionally, North American companies are well-positioned to develop a wide range of pet biotic products, including dry and wet foods, treats, and supplements. Furthermore, supportive regulatory frameworks, robust distribution networks, and considerable investment in R&D and product innovation are expected to drive consumption and market leadership in the pet biotic segment. In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the pet biotics market. • By Company Type: Tier 1 – 30%, Tier 2 – 25%, and Tier 3 – 45% • By Designation: Directors – 25%, Managers – 35%, Others – 40% • By Region: North America – 20%, Europe – 30%, Asia Pacific – 35%, South America – 10%, and Rest of the World – 5% Prominent companies in the market include ADM (US), Alltech (US), Kerry Group plc (Ireland), International Flavors & Fragrances Inc. (US), dsm-firmenich (Netherlands), Cargill, Incorporated (US), Probi (Sweden), Kemin Industries, Inc. (US), BENEO GmbH (Germany), Ingredion (US), Lallemand Inc. (Canada), Sacco System (Italy), Phileo by Lesaffre (France), Sanzyme Biologics (India), Orffa (Netherlands), BIO-CAT (US), and others. Research Coverage This research report categorizes the pet biotics market by type (probiotics, prebiotics, and postbiotics), application (dry food, wet food, supplements, and snacks & treats), pet (dogs, cats, and other pets), function (digestive/gut health, immune modulation, metabolic & weight management, oral & dental health, other functions), manufacturing technology (qualitative) (fermentation, centrifugation & filtration, drying & stabilization, encapsulation & protection, inactivation & cell disruption, formulation & blending, and quality control & storage), and region (North America, Europe, Asia Pacific, South America, and Rest of the World). The report’s scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the pet biotic industry. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the pet biotics market. This report provides a competitive analysis of emerging startups in the pet biotics market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others. Reasons to Buy This Report The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall pet biotics and its subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market, providing them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights into the following pointers: • Analysis of key drivers (rising pet humanization and preventive health focus), restraints (heat and moisture sensitivity of microbial strains), opportunities (rising demand for gut-health-focused and functional pet foods), and challenges (supply chain complexity for live microbes) influencing the growth of the pet biotics market • Product Development/Innovation: Detailed insights into research & development activities and new product launches in the pet biotics market • Market Development: Comprehensive information about lucrative markets—analysis of pet biotics across varied regions • Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the pet biotics market • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as ADM (US), Alltech (US), Kerry Group plc (Ireland), International Flavors & Fragrances Inc. (US), dsm-firmenich (Netherlands), Cargill, Incorporated (US), Probi (Sweden), Kemin Industries, Inc. (US), BENEO GmbH (Germany), Ingredion (US), Lallemand Inc. (Canada), Sacco System (Italy), Phileo by Lesaffre (France), Sanzyme Biologics (India), Orffa (Netherlands), BIO-CAT (US), and other players in the pet biotics market.

目錄 Table of Contents

1 INTRODUCTION 29 1.1 STUDY OBJECTIVES 29 1.2 MARKET DEFINITION 29 1.3 STUDY SCOPE AND SEGMENTATION 29 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 30 1.3.2 INCLUSIONS AND EXCLUSIONS 31 1.3.3 YEARS CONSIDERED 31 1.3.4 CURRENCY CONSIDERED 32 1.3.5 UNIT CONSIDERED 32 1.4 STAKEHOLDERS 33 2 EXECUTIVE SUMMARY 34 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 34 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 35 2.3 DISRUPTIVE TRENDS IN PET BIOTICS MARKET 36 2.4 HIGH-GROWTH SEGMENTS 37 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 38 3 PREMIUM INSIGHTS 39 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PET BIOTICS MARKET 39 3.2 PET BIOTICS MARKET, BY PET AND REGION 40 3.3 PET BIOTICS MARKET, BY TYPE 40 3.4 PET BIOTICS MARKET, BY PET 41 3.5 PET BIOTICS MARKET, BY APPLICATION 41 3.6 PET BIOTICS MARKET, BY FORM 41 3.7 PET BIOTICS MARKET, BY COUNTRY 42 4 MARKET OVERVIEW 43 4.1 INTRODUCTION 43 4.2 MARKET DYNAMICS 44 4.2.1 DRIVERS 44 4.2.1.1 Surge in pet adoption rates 44 4.2.1.2 Rise in pet humanization and focus on preventive health 45 4.2.1.3 Growing veterinary recommendations and clinical backing 45 4.2.1.4 Premiumization and functional food trends 46 4.2.2 RESTRAINTS 47 4.2.2.1 Heat and moisture sensitivity of probiotic strains 47 4.2.2.2 Shelf-life viability concerns 47 4.2.3 OPPORTUNITIES 48 4.2.3.1 Innovation in ingredient formulation 48 4.2.3.2 Rising demand for gut-health-focused and functional pet foods 49 4.2.3.3 Increase in pet expenditure with substantial increase in pet food expenditure 49 4.2.3.4 Increase in urban pet lifestyle experiences: Pet cafés, rentals, and pet-friendly travel 50 4.2.4 CHALLENGES 51 4.2.4.1 Supply chain complexity for live microbes 51 4.2.4.2 Competition from alternative digestive health solutions 51 4.3 UNMET NEEDS AND WHITE SPACES 52 4.3.1 UNMET NEEDS IN PET BIOTICS MARKET 52 4.3.2 WHITE SPACE OPPORTUNITIES – SYNBIOTIC (COMBINATION OF PROBIOTICS & PREBIOTICS) 53 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 53 4.4.1 INTERCONNECTED MARKETS 53 4.4.2 CROSS-SECTOR OPPORTUNITIES 54 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 55 4.5.1 KEY MOVES AND STRATEGIC FOCUS 55 5 INDUSTRY TRENDS 56 5.1 PORTER’S FIVE FORCES ANALYSIS 56 5.1.1 THREAT OF NEW ENTRANTS 57 5.1.2 THREAT OF SUBSTITUTES 57 5.1.3 BARGAINING POWER OF SUPPLIERS 57 5.1.4 BARGAINING POWER OF BUYERS 58 5.1.5 INTENSITY OF COMPETITIVE RIVALRY 58 5.2 MACROECONOMICS OUTLOOK 58 5.2.1 INTRODUCTION 58 5.2.2 SHIFT TOWARD PREVENTIVE PET HEALTH THROUGH SUPPLEMENT ADOPTION 58 5.2.3 EXPANSION OF PET INSURANCE COVERAGE GLOBALLY 59 5.2.4 ECO-CONSCIOUS PET OWNERSHIP DRIVING DEMAND FOR BIOTIC-BASED PET PRODUCTS 60 5.3 VALUE CHAIN ANALYSIS 61 5.3.1 RESEARCH & DEVELOPMENT 62 5.3.2 SOURCING 62 5.3.3 PRODUCTION & PROCESSING 62 5.3.4 DISTRIBUTION 62 5.3.5 MARKETING & SALES 62 5.3.6 END USERS 63 5.4 ECOSYSTEM ANALYSIS 63 5.4.1 DEMAND SIDE 63 5.4.2 SUPPLY SIDE 63 5.5 PRICING ANALYSIS 65 5.5.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY LIVESTOCK 65 5.5.2 AVERAGE SELLING PRICE TREND OF PET BIOTICS, BY REGION, 2021–2024 66 5.6 TRADE ANALYSIS 66 5.6.1 IMPORT SCENARIO OF HS CODE 3002 66 5.6.2 EXPORT SCENARIO OF HS CODE 3002 68 5.7 KEY CONFERENCES AND EVENTS, 2025–2026 69 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 69 5.9 INVESTMENT AND FUNDING SCENARIO 70 5.10 CASE STUDY ANALYSIS 70 5.10.1 STABILIZED PLANT-BASED PROBIOTIC INTEGRATION BY A&B INGREDIENTS TO ENHANCE DIGESTIVE AND SKIN HEALTH IN DOGS 70 5.10.2 PROBIOWORLD’S DUAL-ACTION PET BIOTIC FORMULATION FOR DENTAL AND GUT HEALTH ENHANCEMENT 71 5.10.3 CHR. HANSEN (PART OF NOVONESIS GROUP) – PIONEERING SCIENCE-BASED PROBIOTICS PORTFOLIO FOR EVERY PET LIFE STAGE 71 5.11 IMPACT OF 2025 US TARIFF – PET BIOTICS MARKET 72 5.11.1 INTRODUCTION 72 5.11.2 KEY TARIFF RATES 73 5.11.3 PRICE IMPACT ANALYSIS 74 5.11.4 IMPACT ON COUNTRIES/REGIONS 74 5.11.4.1 US 74 5.11.4.2 Europe 75 5.11.4.3 Asia Pacific 75 5.11.5 IMPACT ON END-USE INDUSTRIES 75 6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 76 6.1 TECHNOLOGY ANALYSIS 76 6.1.1 KEY TECHNOLOGIES 76 6.1.1.1 Fermentation 76 6.1.1.2 Filtration 77 6.1.1.3 Freeze-drying (Lyophilization) 77 6.1.1.4 Microencapsulation and nanoencapsulation 77 6.1.2 COMPLEMENTARY TECHNOLOGIES 78 6.1.2.1 IoT-based fermentation monitoring 78 6.1.2.2 Enzymatic hydrolysis 79 6.1.3 ADJACENT TECHNOLOGIES 79 6.1.3.1 Genome-scale metabolic modeling 79 6.1.3.2 Bioinformatics 79 6.1.3.3 Digital fermentation control 79 6.1.4 TECHNOLOGY/PRODUCT ROADMAP 80 6.1.4.1 Short-term | Foundation & Early Commercialization 80 6.1.4.2 Mid-term | Expansion & Standardization 80 6.1.4.3 Long-term | Mass Commercialization & Disruption 80 6.2 PATENT ANALYSIS 81 6.3 FUTURE APPLICATIONS 83 6.3.1 PSYCHOBIOTICS FOR BEHAVIORAL AND COGNITIVE HEALTH IN PETS 83 6.3.2 SYNBIOTICS AS NEXT-GENERATION GUT HEALTH SOLUTIONS IN PETS 84 6.3.3 ENGINEERED/BREED-PRECISION PROBIOTIC STRAINS FOR PET HEALTH 84 6.3.4 MICROBIOME-LINKED DIAGNOSTIC TOOLS FOR TARGETED PET BIOTIC THERAPIES 85 6.3.5 SPORE-BASED PROBIOTICS FOR SHELF-STABLE, HIGH-TEMPERATURE PET FOOD PROCESSING 86 6.4 IMPACT OF GEN AI ON PET FOOD INDUSTRY 87 6.4.1 TOP USE CASES AND MARKET POTENTIAL 87 6.4.2 BEST PRACTICE OF GEN AI IN PET FOOD INDUSTRY 88 6.4.3 CASE STUDIES OF AI IMPLEMENTATION IN PET INDUSTRY 88 6.4.3.1 CanBiocin’s data-intelligent approach to enhancing fermentation efficiency and yield 88 6.4.3.2 Harmonizing formulation systems: PPF’s pan-European implementation of BESTMIX Recipe Management 89 6.4.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 90 6.4.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PET BIOTICS 90 6.4.6 IMPACT OF AI/GENERATIVE AI ON PET BIOTICS MARKET 90 6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 91 7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 92 7.1 REGIONAL REGULATIONS AND COMPLIANCE 92 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92 7.1.2 INDUSTRY STANDARDS 94 7.1.3 LABELING REQUIREMENTS AND CLAIMS 95 7.1.4 ANTICIPATED REGULATORY CHANGES IN NEXT 5–10 YEARS 96 7.1.4.1 Mandatory validation of CFU viability & functional claims 96 7.1.4.2 Global harmonization of pet biotics ingredient approvals 96 7.1.4.3 Enhanced safety and antimicrobial-resistance (AMR) risk evaluation 96 7.1.4.4 Digital labeling, data transparency, and smart packaging requirements 96 7.2 SUSTAINABILITY INITIATIVES 96 7.2.1 SUSTAINABLE SOURCING 97 7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES 97 7.2.3 CIRCULAR ECONOMY APPROACHES 98 7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 98 7.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 99 8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 100 8.1 DECISION-MAKING PROCESS 100 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 102 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 102 8.2.2 BUYING CRITERIA 103 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 103 8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES 104 8.5 MARKET PROFITABILITY 105 8.6 REVENUE POTENTIAL 106 8.6.1 COST DYNAMICS 106 8.6.2 MARGIN OPPORTUNITIES, BY INGREDIENT SOURCE 107 9 PET BIOTICS MARKET, BY TYPE 108 9.1 INTRODUCTION 109 9.2 PROBIOTICS 111 9.2.1 BACTERIA 113 9.2.1.1 Driving Digestive Strength and Immune Resilience in Companion Animals Through Science-backed Bacterial Probiotics 113 9.2.1.2 Lactobacillus 115 9.2.1.3 Bifidobacterium 115 9.2.1.4 Enterococcus 116 9.2.1.5 Bacillus 117 9.2.1.6 Streptococcus thermophilus 118 9.2.2 YEAST & FUNGI 119 9.2.2.1 Advanced yeast solutions transforming digestive wellness in companion animals 119 9.2.2.2 Saccharomyces cerevisiae 121 9.2.2.3 Saccharomyces Boulardii 122 9.3 PREBIOTICS 123 9.3.1 STRENGTHENING GUT ECOLOGY FOR LONG-TERM VITALITY AND IMMUNE STRENGTH 123 9.3.2 OLIGOSACCHARIDES 125 9.3.2.1 Fructooligosaccharides (FOS) 127 9.3.2.2 Mannanoligosaccharides (MOS) 127 9.3.2.3 Galactooligosaccharides (GOS) 128 9.3.3 INULIN 129 9.3.4 POLYDEXTROSE 130 9.3.5 OTHER PREBIOTIC TYPES 131 9.4 POSTBIOTICS 132 9.4.1 PREMIUM POSTBIOTIC SOLUTIONS DESIGNED FOR STABILITY, SAFETY, AND SUPERIOR PERFORMANCE 132 9.4.2 BACTERIA 134 9.4.2.1 Lactobacillus 135 9.4.2.2 Bifidobacterium 135 9.4.2.3 Other bacteria 136 9.5 YEAST & FUNGI 136 9.5.1 FUNCTIONAL YEAST INNOVATION SHAPING FUTURE OF PET WELLNESS 136 9.5.2 SACCHAROMYCES CEREVISIAE 138 9.5.3 SACCHAROMYCES BOULARDII 138 10 PET BIOTICS MARKET, BY APPLICATION 139 10.1 INTRODUCTION 140 10.1.1 DRY FOOD 141 10.1.1.1 Long-lasting gut health protection in every crunchy bite 141 10.1.2 WET FOOD 142 10.1.2.1 Smooth integration, stronger digestion—biotics that thrive in wet formats 142 10.1.3 SUPPLEMENTS 143 10.1.3.1 Premium supplement solutions for proactive pet well-being 143 10.1.4 SNACKS & TREATS 145 10.1.4.1 Reward with purpose—treats enriched with biotics for everyday vitality 145 11 PET BIOTICS MARKET, BY FORM 147 11.1 INTRODUCTION 148 11.2 DRY 149 11.2.1 STABLE, SCALABLE, AND SCIENCE-FORWARD—DRY BIOTICS POWERING NEXT-GENERATION PET WELLNESS 149 11.3 LIQUID 150 11.3.1 EASE OF INCORPORATION, PRECISION DOSING, AND SMOOTH DELIVERY FOR SENSITIVE AND RECOVERING PETS TO DRIVE DEMAND 150 12 PET BIOTICS MARKET, BY PET 152 12.1 INTRODUCTION 153 12.2 DOGS 154 12.2.1 DAILY GUT AND IMMUNE SUPPORT FOR HEALTHIER, HAPPIER CANINE COMPANIONS 154 12.3 CATS 155 12.3.1 GENTLE, TARGETED GUT SUPPORT CRAFTED FOR SENSITIVE FELINE DIGESTION 155 12.4 OTHER PETS 156 13 PET BIOTICS MARKET, BY FUNCTION 157 13.1 INTRODUCTION 158 13.2 DIGESTIVE/GUT HEALTH 159 13.3 IMMUNE MODULATION 160 13.4 METABOLIC & WEIGHT MANAGEMENT 160 13.5 ORAL & DENTAL HEALTH 160 13.6 OTHER FUNCTIONS 161 14 PET BIOTICS MARKET, BY MANUFACTURING TECHNOLOGY 162 14.1 INTRODUCTION 162 14.2 FERMENTATION 162 14.3 CENTRIFUGATION & FILTRATION 163 14.4 DRYING & STABILIZATION 164 14.5 ENCAPSULATION & PROTECTION 165 14.6 INACTIVATION & CELL DISRUPTION 165 14.7 FORMULATION & BLENDING 166 14.8 QUALITY CONTROL & STORAGE 166 15 PET BIOTICS MARKET, BY REGION 168 15.1 INTRODUCTION 169 15.2 NORTH AMERICA 171 15.2.1 US 175 15.2.1.1 Global hub for pet biotics innovation, powered by presence of leading ingredient and technology companies 175 15.2.2 CANADA 177 15.2.2.1 Rising hub for functional pet nutrition and microbiome wellness 177 15.2.3 MEXICO 179 15.2.3.1 Rising market for digestive wellness and microbiome nutrition 179 15.3 EUROPE 180 15.3.1 GERMANY 183 15.3.1.1 Strong consumer demand for pet biotics to drive market 183 15.3.2 UK 185 15.3.2.1 Expanding companion-animal base to drive market 185 15.3.3 FRANCE 187 15.3.3.1 Rising health concerns to strengthen demand for pet biotics 187 15.3.4 ITALY 188 15.3.4.1 Growing pet humanization and premium nutrition trends to fuel market 188 15.3.5 SPAIN 189 15.3.5.1 Wellness-driven pet culture to accelerate pet biotics adoption 189 15.3.6 REST OF EUROPE 191 15.4 ASIA PACIFIC 192 15.4.1 CHINA 196 15.4.1.1 Rapid urban growth and wellness priorities to drive market 196 15.4.2 JAPAN 198 15.4.2.1 Health, premiumization, and sustainability to drive demand for pet biotics 198 15.4.3 INDIA 199 15.4.3.1 Consumer shift toward functional and preventive nutrition products to drive market 199 15.4.4 AUSTRALIA & NEW ZEALAND 201 15.4.4.1 Demand for premium and functional nutrition to support market growth 201 15.4.5 REST OF ASIA PACIFIC 202 15.5 SOUTH AMERICA 204 15.5.1 BRAZIL 207 15.5.1.1 Expanding pet market to drive demand for pet biotics 207 15.5.2 ARGENTINA 208 15.5.2.1 Steady pet market growth to fuel pet biotics demand 208 15.5.3 REST OF SOUTH AMERICA 209 15.6 REST OF THE WORLD 211 15.6.1 MIDDLE EAST 214 15.6.1.1 Rising pet humanization and urbanization to fuel demand for pet biotics 214 15.6.2 AFRICA 215 15.6.2.1 Growing focus on pet health to drive market 215 16 COMPETITIVE LANDSCAPE 217 16.1 OVERVIEW 217 16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 217 16.3 REVENUE ANALYSIS 219 16.4 MARKET SHARE ANALYSIS 219 16.5 COMPANY VALUATION AND FINANCIAL METRICS 222 16.5.1 COMPANY VALUATION 222 16.5.2 FINANCIAL METRICS 222 16.6 BRAND/PRODUCT COMPARISON 223 16.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 224 16.7.1 STARS 224 16.7.2 EMERGING LEADERS 225 16.7.3 PERVASIVE PLAYERS 225 16.7.4 PARTICIPANTS 225 16.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 227 16.7.5.1 Company footprint 227 16.7.5.2 Regional footprint 227 16.7.5.3 Type footprint 228 16.7.5.4 Pet footprint 228 16.7.5.5 Application footprint 229 16.7.5.6 Form footprint 230 16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 230 16.8.1 PROGRESSIVE COMPANIES 230 16.8.2 RESPONSIVE COMPANIES 231 16.8.3 DYNAMIC COMPANIES 231 16.8.4 STARTING BLOCKS 231 16.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 232 16.9 COMPETITIVE SCENARIO AND TRENDS 234 16.9.1 PRODUCT LAUNCHES 234 16.9.2 DEALS 234 16.9.3 EXPANSIONS 237 16.9.4 OTHER DEVELOPMENTS 238 17 COMPANY PROFILES 239 17.1 KEY PLAYERS 239 17.1.1 ADM 239 17.1.1.1 Business overview 239 17.1.1.2 Products/Services/Solutions offered 240 17.1.1.3 Recent developments 241 17.1.1.3.1 Expansions 241 17.1.1.4 MnM view 242 17.1.1.4.1 Key strengths 242 17.1.1.4.2 Strategic choices 242 17.1.1.4.3 Weaknesses & competitive threats 242 17.1.2 ALLTECH (US) 243 17.1.2.1 Business overview 243 17.1.2.2 Products/Services/Solutions offered 243 17.1.2.3 Recent developments 245 17.1.2.3.1 Product launches 245 17.1.2.4 MnM view 245 17.1.2.4.1 Key strengths 245 17.1.2.4.2 Strategic choices 245 17.1.2.4.3 Weaknesses & competitive threats 245 17.1.3 KERRY GROUP PLC 246 17.1.3.1 Business overview 246 17.1.3.2 Products/Services/Solutions offered 247 17.1.3.3 Recent developments 248 17.1.3.3.1 Deals 248 17.1.3.4 MnM view 248 17.1.3.4.1 Key strengths 248 17.1.3.4.2 Strategic choices 248 17.1.3.4.3 Weaknesses & competitive threats 249 17.1.4 INTERNATIONAL FLAVORS & FRAGRANCES INC 250 17.1.4.1 Business overview 250 17.1.4.2 Products/Services/Solutions offered 251 17.1.4.3 Recent developments 251 17.1.4.4 MnM view 252 17.1.4.4.1 Key strengths 252 17.1.4.4.2 Strategic choices 252 17.1.4.4.3 Weaknesses & competitive threats 252 17.1.5 DSM-FIRMENICH 253 17.1.5.1 Business overview 253 17.1.5.2 Products/Services/Solutions offered 255 17.1.5.3 Recent developments 255 17.1.5.3.1 Deals 255 17.1.5.4 MnM view 256 17.1.5.4.1 Key strengths 256 17.1.5.4.2 Strategic choices 256 17.1.5.4.3 Weaknesses & competitive threats 256 17.1.6 CARGILL, INCORPORATED 257 17.1.6.1 Business overview 257 17.1.6.2 Products/Services/Solutions offered 258 17.1.6.3 Recent developments 259 17.1.6.3.1 Deals 259 17.1.6.3.2 Expansions 259 17.1.6.3.3 Other developments 260 17.1.6.4 MnM view 260 17.1.6.4.1 Key strengths 260 17.1.6.4.2 Strategic choices 261 17.1.6.4.3 Weaknesses & competitive threats 261 17.1.7 PROBI 262 17.1.7.1 Business overview 262 17.1.7.2 Products/Services/Solutions offered 263 17.1.7.3 Recent developments 264 17.1.7.3.1 Deals 264 17.1.7.4 MnM view 264 17.1.8 INGREDION (US) 265 17.1.8.1 Business overview 265 17.1.8.2 Products/Services/Solutions offered 266 17.1.8.3 Recent developments 266 17.1.8.4 MnM view 266 17.1.9 KEMIN INDUSTRIES, INC. 267 17.1.9.1 Business overview 267 17.1.9.2 Products/Services/Solutions offered 267 17.1.9.3 MnM view 267 17.1.10 BENEO GMBH 268 17.1.10.1 Business overview 268 17.1.10.2 Products/Services/Solutions offered 268 17.1.10.3 Recent developments 269 17.1.10.3.1 Other Developments 269 17.1.10.4 MnM view 269 17.1.11 PHILEO BY LESAFFRE 270 17.1.11.1 Business overview 270 17.1.11.2 Products/Services/Solutions offered 270 17.1.11.3 Recent developments 271 17.1.11.3.1 Deals 271 17.1.11.4 MnM view 271 17.1.12 LALLEMAND INC. 272 17.1.12.1 Business overview 272 17.1.12.2 Products/Services/Solutions offered 272 17.1.12.3 Recent developments 274 17.1.12.4 MnM view 274 17.1.13 SACCO SYSTEM 275 17.1.13.1 Business overview 275 17.1.13.2 Products/Services/Solutions offered 275 17.1.13.3 Recent developments 276 17.1.13.4 MnM view 276 17.1.14 SANZYME BIOLOGICS 277 17.1.14.1 Business overview 277 17.1.14.2 Products/Services/Solutions offered 277 17.1.14.3 Recent developments 278 17.1.14.4 MnM view 278 17.1.15 ORFFA 279 17.1.15.1 Business overview 279 17.1.15.2 Products/Services/Solutions offered 279 17.1.15.3 Recent developments 280 17.1.15.4 MnM view 280 17.2 STARTUPS/SMES 281 17.2.1 SYNBIO TECH INC. 281 17.2.1.1 Business overview 281 17.2.1.2 Products/Services/Solutions offered 281 17.2.1.3 Recent developments 282 17.2.1.4 MnM view 283 17.2.2 CANBIOCIN INC. 284 17.2.2.1 Business overview 284 17.2.2.2 Products/Services/Solutions offered 284 17.2.2.3 Recent developments 285 17.2.2.3.1 Deals 285 17.2.2.4 MnM view 285 17.2.3 BIO-CAT 286 17.2.3.1 Business overview 286 17.2.3.2 Products/Services/Solutions offered 286 17.2.3.3 Recent developments 287 17.2.3.3.1 Deals 287 17.2.3.4 MnM view 287 17.2.4 SPECIALTY ENZYMES & PROBIOTICS 288 17.2.4.1 Business overview 288 17.2.4.2 Products/Services/Solutions offered 288 17.2.4.3 Recent developments 289 17.2.4.3.1 Product launches 289 17.2.4.4 MnM view 289 17.2.5 CREATIVE ENZYMES 290 17.2.5.1 Business overview 290 17.2.5.2 Products/Services/Solutions offered 290 17.2.5.3 Recent developments 290 17.2.5.4 MnM view 291 17.2.6 VERB BIOTICS 292 17.2.7 BIOTENOVA SDN. BHD. 293 17.2.8 BIOPROX HEALTHCARE 294 17.2.9 PELLUCID LIFESCIENCES PVT. LTD 295 17.2.10 HOLLISON, LLC. (US) 296 18 RESEARCH METHODOLOGY 297 18.1 RESEARCH DATA 297 18.1.1 SECONDARY DATA 297 18.1.1.1 Key data from secondary sources 298 18.1.2 PRIMARY DATA 298 18.1.2.1 Key data from primary sources 298 18.1.2.2 Breakdown of primary profiles 299 18.1.2.3 Key insights from industry experts 300 18.2 MARKET SIZE ESTIMATION 300 18.2.1 TOP-DOWN APPROACH 301 18.2.2 SUPPLY-SIDE ANALYSIS 302 18.2.3 BOTTOM-UP APPROACH (DEMAND SIDE) 303 18.3 DATA TRIANGULATION AND MARKET BREAKUP 304 18.4 RESEARCH ASSUMPTIONS 305 18.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 305 19 ADJACENT & RELATED MARKETS 306 19.1 INTRODUCTION 306 19.2 STUDY LIMITATIONS 306 19.3 PET SUPPLEMENTS MARKET 306 19.3.1 MARKET DEFINITION 306 19.3.2 MARKET OVERVIEW 307 19.4 PET FOOD INGREDIENTS MARKET 307 19.4.1 MARKET DEFINITION 307 19.4.2 MARKET OVERVIEW 308 20 APPENDIX 309 20.1 DISCUSSION GUIDE 309 20.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 317 20.3 CUSTOMIZATION OPTIONS 319 20.4 RELATED REPORTS 319

圖表清單 List of Tables & Figures

TABLE 1 USD EXCHANGE RATES, 2020–2024 32 TABLE 2 KEY MOVES AND STRATEGIC FOCUS 55 TABLE 3 IMPACT OF PORTER’S FIVE FORCES ON PET BIOTICS MARKET 57 TABLE 4 ROLES OF COMPANIES IN PET BIOTICS MARKET ECOSYSTEM 64 TABLE 5 IMPORT SCENARIO FOR HS CODE: 3002, BY COUNTRY, 2020–2024 (TONS) 67 TABLE 6 EXPORT SCENARIO FOR HS CODE: 3002, BY COUNTRY, 2020–2024 (TONS) 68 TABLE 7 PET BIOTICS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025–2026 69 TABLE 8 US-ADJUSTED RECIPROCAL TARIFF RATES 73 TABLE 9 LIST OF MAJOR PATENTS PERTAINING TO PET BIOTICS MARKET, 2020–2025 81 TABLE 10 TOP USE CASES AND MARKET POTENTIAL 87 TABLE 11 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 90 TABLE 12 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 91 TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92 TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93 TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93 TABLE 16 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 TABLE 17 GLOBAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 TABLE 18 GLOBAL INDUSTRY STANDARDS IN PET BIOTICS MARKET 95 TABLE 19 LABELING REQUIREMENTS AND CLAIMS IN PET BIOTICS MARKET 95 TABLE 20 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN PET BIOTICS MARKET 99 TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 102 TABLE 22 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 103 TABLE 23 UNMET NEEDS IN PET BIOTICS MARKET, BY APPLICATION INDUSTRY (SUPPLY CHAIN) 104 TABLE 24 COST DYNAMICS IN PET BIOTICS MARKET 106 TABLE 25 MARGIN OPPORTUNITIES IN PET BIOTICS MARKET, BY INGREDIENT SOURCE 107 TABLE 26 PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 110 TABLE 27 PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 110 TABLE 28 PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS) 110 TABLE 29 PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS) 110 TABLE 30 PROBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 111 TABLE 31 PROBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 112 TABLE 32 PROBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (TONS) 112 TABLE 33 PROBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (TONS) 112 TABLE 34 PROBIOTICS: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 112 TABLE 35 PROBIOTICS: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 113 TABLE 36 BACTERIA: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2021–2024 (USD MILLION) 113 TABLE 37 BACTERIA: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2025–2030 (USD MILLION) 114 TABLE 38 BACTERIA: PET BIOTICS MARKET FOR PROBIOTICS, BY SUBTYPE, 2021–2024 (USD MILLION) 114 TABLE 39 BACTERIA: PET BIOTICS MARKET FOR PROBIOTICS, BY SUBTYPE, 2025–2030 (USD MILLION) 114 TABLE 40 LACTOBACILLUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2021–2024 (USD MILLION) 115 TABLE 41 LACTOBACILLUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2025–2030 (USD MILLION) 115 TABLE 42 BIFIDOBACTERIUM: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2021–2024 (USD MILLION) 116 TABLE 43 BIFIDOBACTERIUM: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2025–2030 (USD MILLION) 116 TABLE 44 ENTEROCOCCUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2021–2024 (USD MILLION) 117 TABLE 45 ENTEROCOCCUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2025–2030 (USD MILLION) 117 TABLE 46 BACILLUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2021–2024 (USD MILLION) 118 TABLE 47 BACILLUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2025–2030 (USD MILLION) 118 TABLE 48 STREPTOCOCCUS THERMOPHILUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2021–2024 (USD MILLION) 119 TABLE 49 STREPTOCOCCUS THERMOPHILUS: PET BIOTICS MARKET FOR PROBIOTICS, BY REGION, 2025–2030 (USD MILLION) 119 TABLE 50 YEAST & FUNGI: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 120 TABLE 51 YEAST & FUNGI: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 120 TABLE 52 YEAST & FUNGI: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 120 TABLE 53 YEAST & FUNGI: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 120 TABLE 54 SACCHAROMYCES CEREVISIAE: PET BIOTICS MARKET FOR YEAST & FUNGI, BY REGION, 2021–2024 (USD MILLION) 121 TABLE 55 SACCHAROMYCES CEREVISIAE: PET BIOTICS MARKET FOR YEAST & FUNGI, BY REGION, 2025–2030 (USD MILLION) 121 TABLE 56 SACCHAROMYCES BOULARDII: PET BIOTICS MARKET FOR YEAST & FUNGI, BY REGION, 2021–2024 (USD MILLION) 122 TABLE 57 SACCHAROMYCES BOULARDII: PET BIOTICS MARKET FOR YEAST & FUNGI, BY REGION, 2025–2030 (USD MILLION) 122 TABLE 58 PREBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 123 TABLE 59 PREBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 123 TABLE 60 PREBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (TONS) 124 TABLE 61 PREBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (TONS) 124 TABLE 62 PREBIOTICS: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 124 TABLE 63 PREBIOTICS: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 125 TABLE 64 OLIGOSACCHARIDES: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2021–2024 (USD MILLION) 125 TABLE 65 OLIGOSACCHARIDES: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2025–2030 (USD MILLION) 126 TABLE 66 OLIGOSACCHARIDES: PET BIOTICS MARKET FOR PREBIOTICS, BY TYPE, 2021–2024 (USD MILLION) 126 TABLE 67 OLIGOSACCHARIDES: PET BIOTICS MARKET FOR PREBIOTICS, BY TYPE, 2025–2030 (USD MILLION) 126 TABLE 68 FOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2021–2024 (USD MILLION) 127 TABLE 69 FOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2025–2030 (USD MILLION) 127 TABLE 70 MOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2021–2024 (USD MILLION) 128 TABLE 71 MOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2025–2030 (USD MILLION) 128 TABLE 72 GOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2021–2024 (USD MILLION) 128 TABLE 73 GOS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2025–2030 (USD MILLION) 129 TABLE 74 INULIN: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2021–2024 (USD MILLION) 129 TABLE 75 INULIN: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2025–2030 (USD MILLION) 130 TABLE 76 POLYDEXTROSE: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2021–2024 (USD MILLION) 130 TABLE 77 POLYDEXTROSE: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2025–2030 (USD MILLION) 131 TABLE 78 OTHER PREBIOTICS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2021–2024 (USD MILLION) 131 TABLE 79 OTHER PREBIOTICS: PET BIOTICS MARKET FOR PREBIOTICS, BY REGION, 2025–2030 (USD MILLION) 132 TABLE 80 POSTBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 132 TABLE 81 POSTBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 133 TABLE 82 POSTBIOTICS: PET BIOTICS MARKET, BY REGION, 2021–2024 (TONS) 133 TABLE 83 POSTBIOTICS: PET BIOTICS MARKET, BY REGION, 2025–2030 (TONS) 133 TABLE 84 POSTBIOTICS: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 134 TABLE 85 POSTBIOTICS: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 134 TABLE 86 BACTERIA: PET BIOTICS MARKET FOR POSTBIOTICS, BY REGION, 2021–2024 (USD MILLION) 134 TABLE 87 BACTERIA: PET BIOTICS MARKET FOR POSTBIOTICS, BY REGION, 2025–2030 (USD MILLION) 135 TABLE 88 BACTERIA: PET BIOTICS MARKET FOR POSTBIOTICS, BY TYPE, 2021–2024 (USD MILLION) 135 TABLE 89 BACTERIA: PET BIOTICS MARKET FOR POSTBIOTICS, BY TYPE, 2025–2030 (USD MILLION) 135 TABLE 90 YEAST & FUNGI: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 137 TABLE 91 YEAST & FUNGI: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 137 TABLE 92 YEAST & FUNGI: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 137 TABLE 93 YEAST & FUNGI: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 137 TABLE 94 PET BIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 140 TABLE 95 PET BIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 141 TABLE 96 DRY FOOD: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 142 TABLE 97 DRY FOOD: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 142 TABLE 98 WET FOOD: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 143 TABLE 99 WET FOOD: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 143 TABLE 100 SUPPLEMENTS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 144 TABLE 101 SUPPLEMENTS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 144 TABLE 102 SNACKS & TREATS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 145 TABLE 103 SNACKS & TREATS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 146 TABLE 104 PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 148 TABLE 105 PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 148 TABLE 106 DRY: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 149 TABLE 107 DRY: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 150 TABLE 108 LIQUID: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 151 TABLE 109 LIQUID: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 151 TABLE 110 PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 154 TABLE 111 PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 154 TABLE 112 DOGS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 154 TABLE 113 DOGS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 155 TABLE 114 CATS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 155 TABLE 115 CATS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 156 TABLE 116 OTHER PETS: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 156 TABLE 117 OTHER PETS: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 156 TABLE 118 PET BIOTICS MARKET, BY FUNCTION, 2021–2024 (USD MILLION) 159 TABLE 119 PET BIOTICS MARKET, BY FUNCTION, 2025–2030 (USD MILLION) 159 TABLE 120 PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 170 TABLE 121 PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 170 TABLE 122 PET BIOTICS MARKET, BY REGION, 2021–2024 (TONS) 170 TABLE 123 PET BIOTICS MARKET, BY REGION, 2025–2030 (TONS) 171 TABLE 124 NORTH AMERICA: PET BIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 172 TABLE 125 NORTH AMERICA: PET BIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 172 TABLE 126 NORTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 173 TABLE 127 NORTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 173 TABLE 128 NORTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS) 173 TABLE 129 NORTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS) 173 TABLE 130 NORTH AMERICA: PET BIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 174 TABLE 131 NORTH AMERICA: PET BIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 174 TABLE 132 NORTH AMERICA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 174 TABLE 133 NORTH AMERICA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 174 TABLE 134 NORTH AMERICA: PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 175 TABLE 135 NORTH AMERICA: PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 175 TABLE 136 US: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 176 TABLE 137 US: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 176 TABLE 138 US: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 176 TABLE 139 US: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 176 TABLE 140 CANADA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 178 TABLE 141 CANADA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 178 TABLE 142 CANADA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 178 TABLE 143 CANADA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 178 TABLE 144 MEXICO: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 179 TABLE 145 MEXICO: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 179 TABLE 146 MEXICO: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 179 TABLE 147 MEXICO: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 180 TABLE 148 EUROPE: PET BIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 180 TABLE 149 EUROPE: PET BIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 181 TABLE 150 EUROPE: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 181 TABLE 151 EUROPE: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 181 TABLE 152 EUROPE: PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS) 181 TABLE 153 EUROPE: PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS) 182 TABLE 154 EUROPE: PET BIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 182 TABLE 155 EUROPE: PET BIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 182 TABLE 156 EUROPE: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 182 TABLE 157 EUROPE: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 183 TABLE 158 EUROPE: PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 183 TABLE 159 EUROPE: PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 183 TABLE 160 GERMANY: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 184 TABLE 161 GERMANY: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 184 TABLE 162 GERMANY: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 184 TABLE 163 GERMANY: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 185 TABLE 164 UK: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 186 TABLE 165 UK: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 186 TABLE 166 UK: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 186 TABLE 167 UK: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 186 TABLE 168 FRANCE: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 187 TABLE 169 FRANCE: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 187 TABLE 170 FRANCE: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 187 TABLE 171 FRANCE: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 188 TABLE 172 ITALY: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 188 TABLE 173 ITALY: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 189 TABLE 174 ITALY: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 189 TABLE 175 ITALY: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 189 TABLE 176 SPAIN: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 190 TABLE 177 SPAIN: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 190 TABLE 178 SPAIN: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 190 TABLE 179 SPAIN: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 191 TABLE 180 REST OF EUROPE: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 191 TABLE 181 REST OF EUROPE: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 191 TABLE 182 REST OF EUROPE: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 192 TABLE 183 REST OF EUROPE: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 192 TABLE 184 ASIA PACIFIC: PET BIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 193 TABLE 185 ASIA PACIFIC: PET BIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 194 TABLE 186 ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 194 TABLE 187 ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 194 TABLE 188 ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS) 194 TABLE 189 ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS) 195 TABLE 190 ASIA PACIFIC: PET BIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 195 TABLE 191 ASIA PACIFIC: PET BIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 195 TABLE 192 ASIA PACIFIC: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 195 TABLE 193 ASIA PACIFIC: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 196 TABLE 194 ASIA PACIFIC: PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 196 TABLE 195 ASIA PACIFIC: PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 196 TABLE 196 CHINA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 197 TABLE 197 CHINA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 197 TABLE 198 CHINA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 197 TABLE 199 CHINA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 198 TABLE 200 JAPAN: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 198 TABLE 201 JAPAN: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 199 TABLE 202 JAPAN: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 199 TABLE 203 JAPAN: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 199 TABLE 204 INDIA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 200 TABLE 205 INDIA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 200 TABLE 206 INDIA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 200 TABLE 207 INDIA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 201 TABLE 208 AUSTRALIA & NEW ZEALAND: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 201 TABLE 209 AUSTRALIA & NEW ZEALAND: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 202 TABLE 210 AUSTRALIA & NEW ZEALAND: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 202 TABLE 211 AUSTRALIA & NEW ZEALAND: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 202 TABLE 212 REST OF ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 203 TABLE 213 REST OF ASIA PACIFIC: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 203 TABLE 214 REST OF ASIA PACIFIC: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 203 TABLE 215 REST OF ASIA PACIFIC: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 203 TABLE 216 SOUTH AMERICA: PET BIOTICS MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 204 TABLE 217 SOUTH AMERICA: PET BIOTICS MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 204 TABLE 218 SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 204 TABLE 219 SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 205 TABLE 220 SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS) 205 TABLE 221 SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS) 205 TABLE 222 SOUTH AMERICA: PET BIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 205 TABLE 223 SOUTH AMERICA: PET BIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 206 TABLE 224 SOUTH AMERICA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 206 TABLE 225 SOUTH AMERICA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 206 TABLE 226 SOUTH AMERICA: PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 206 TABLE 227 SOUTH AMERICA: PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 207 TABLE 228 BRAZIL: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 207 TABLE 229 BRAZIL: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 207 TABLE 230 BRAZIL: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 208 TABLE 231 BRAZIL: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 208 TABLE 232 ARGENTINA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 208 TABLE 233 ARGENTINA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 209 TABLE 234 ARGENTINA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 209 TABLE 235 ARGENTINA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 209 TABLE 236 REST OF SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 210 TABLE 237 REST OF SOUTH AMERICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 210 TABLE 238 REST OF SOUTH AMERICA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 210 TABLE 239 REST OF SOUTH AMERICA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 210 TABLE 240 REST OF THE WORLD: PET BIOTICS MARKET, BY REGION, 2021–2024 (USD MILLION) 211 TABLE 241 REST OF THE WORLD: PET BIOTICS MARKET, BY REGION, 2025–2030 (USD MILLION) 211 TABLE 242 REST OF THE WORLD: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 211 TABLE 243 REST OF THE WORLD: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 212 TABLE 244 REST OF THE WORLD: PET BIOTICS MARKET, BY TYPE, 2021–2024 (TONS) 212 TABLE 245 REST OF THE WORLD: PET BIOTICS MARKET, BY TYPE, 2025–2030 (TONS) 212 TABLE 246 REST OF THE WORLD: PET BIOTICS MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 212 TABLE 247 REST OF THE WORLD: PET BIOTICS MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 213 TABLE 248 REST OF THE WORLD: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 213 TABLE 249 REST OF THE WORLD: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 213 TABLE 250 REST OF THE WORLD: PET BIOTICS MARKET, BY FORM, 2021–2024 (USD MILLION) 213 TABLE 251 REST OF THE WORLD: PET BIOTICS MARKET, BY FORM, 2025–2030 (USD MILLION) 214 TABLE 252 MIDDLE EAST: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 214 TABLE 253 MIDDLE EAST: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 214 TABLE 254 MIDDLE EAST: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 215 TABLE 255 MIDDLE EAST: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 215 TABLE 256 AFRICA: PET BIOTICS MARKET, BY TYPE, 2021–2024 (USD MILLION) 215 TABLE 257 AFRICA: PET BIOTICS MARKET, BY TYPE, 2025–2030 (USD MILLION) 216 TABLE 258 AFRICA: PET BIOTICS MARKET, BY PET, 2021–2024 (USD MILLION) 216 TABLE 259 AFRICA: PET BIOTICS MARKET, BY PET, 2025–2030 (USD MILLION) 216 TABLE 260 OVERVIEW OF STRATEGIES ADOPTED BY KEY PET BIOTICS MARKET PLAYERS 217 TABLE 261 PET BIOTICS MARKET: MARKET SHARE ANALYSIS, 2024 220 TABLE 262 PET BIOTICS MARKET: REGIONAL FOOTPRINT, 2024 227 TABLE 263 PET BIOTICS MARKET: TYPE FOOTPRINT, 2024 228 TABLE 264 PET BIOTICS MARKET: PET FOOTPRINT, 2024 228 TABLE 265 PET BIOTICS MARKET: APPLICATION FOOTPRINT, 2024 229 TABLE 266 PET BIOTICS MARKET: FORM FOOTPRINT, 2024 230 TABLE 267 PET BIOTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2024 232 TABLE 268 PET BIOTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 233 TABLE 269 PET BIOTICS MARKET: PRODUCT LAUNCHES, APRIL 2022–SEPTEMBER 2023 234 TABLE 270 PET BIOTICS MARKET: DEALS, JULY 2023 - OCTOBER 2025 234 TABLE 271 PET BIOTICS MARKET: EXPANSIONS, FEBRUARY 2020–NOVEMBER 2025 237 TABLE 272 PET BIOTICS MARKET: OTHER DEVELOPMENTS, NOVEMBER 2024 238 TABLE 273 ADM: BUSINESS OVERVIEW 239 TABLE 274 ADM: PRODUCTS/SERVICES/SOLUTIONS OFFERED 240 TABLE 275 ADM: EXPANSIONS 241 TABLE 276 ALLTECH: COMPANY OVERVIEW 243 TABLE 277 ALLTECH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 243 TABLE 278 ALLTECH: PRODUCT LAUNCHES 245 TABLE 279 KERRY GROUP PLC: COMPANY OVERVIEW 246 TABLE 280 KERRY GROUP PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 247 TABLE 281 KERRY GROUP PLC: DEALS 248 TABLE 282 INTERNATIONAL FLAVORS & FRAGRANCES INC: COMPANY OVERVIEW 250 TABLE 283 INTERNATIONAL FLAVORS & FRAGRANCES INC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 251 TABLE 284 DSM-FIRMENICH: COMPANY OVERVIEW 253 TABLE 285 DSM-FIRMENICH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 255 TABLE 286 DSM-FIRMENICH: DEALS 255 TABLE 287 CARGILL, INCORPORATED: COMPANY OVERVIEW 257 TABLE 288 CARGILL, INCORPORATED: PRODUCTS/SERVICES/SOLUTIONS OFFERED 258 TABLE 289 CARGILL, INCORPORATED: DEALS 259 TABLE 290 CARGILL, INCORPORATED: EXPANSIONS 259 TABLE 291 CARGILL, INCORPORATED: OTHER DEVELOPMENTS 260 TABLE 292 PROBI: COMPANY OVERVIEW 262 TABLE 293 PROBI: PRODUCTS/SERVICES/SOLUTIONS OFFERED 263 TABLE 294 PROBI: DEALS 264 TABLE 295 INGREDION: COMPANY OVERVIEW 265 TABLE 296 INGREDION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 266 TABLE 297 KEMIN INDUSTRIES, INC.: COMPANY OVERVIEW 267 TABLE 298 KEMIN INDUSTRIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 267 TABLE 299 BENEO GMBH: COMPANY OVERVIEW 268 TABLE 300 BENEO GMBH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 268 TABLE 301 BENEO GMBH: OTHER DEVELOPMENTS 269 TABLE 302 PHILEO BY LESAFFRE: COMPANY OVERVIEW 270 TABLE 303 PHILEO BY LESAFFRE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 270 TABLE 304 PHILEO BY LESAFFRE (FRANCE): DEALS 271 TABLE 305 LALLEMAND INC.: COMPANY OVERVIEW 272 TABLE 306 LALLEMAND INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 272 TABLE 307 LALLEMAND INC.: DEALS 274 TABLE 308 SACCO SYSTEM: COMPANY OVERVIEW 275 TABLE 309 SACCO SYSTEM (ITALY): PRODUCTS/SERVICES/SOLUTIONS OFFERED 275 TABLE 310 SANZYME BIOLOGICS: COMPANY OVERVIEW 277 TABLE 311 SANZYME BIOLOGICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 277 TABLE 312 ORFFA: COMPANY OVERVIEW 279 TABLE 313 ORFFA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 279 TABLE 314 SYNBIO TECH INC.: COMPANY OVERVIEW 281 TABLE 315 SYNBIO TECH INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 281 TABLE 316 SYNBIO TECH INC.: EXPANSION 282 TABLE 317 CANBIOCIN INC.: COMPANY OVERVIEW 284 TABLE 318 CANBIOCIN INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 284 TABLE 319 CANBIOCIN INC.: DEALS 285 TABLE 320 BIO-CAT (US): COMPANY OVERVIEW 286 TABLE 321 BIO-CAT: PRODUCTS/SERVICES/SOLUTIONS OFFERED 286 TABLE 322 BIO-CAT: DEALS 287 TABLE 323 SPECIALTY ENZYMES & PROBIOTICS: COMPANY OVERVIEW 288 TABLE 324 SPECIALTY ENZYMES & PROBIOTICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 288 TABLE 325 SPECIALTY ENZYMES & PROBIOTICS: PRODUCT LAUNCHES 289 TABLE 326 CREATIVE ENZYMES: COMPANY OVERVIEW 290 TABLE 327 CREATIVE ENZYMES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 290 TABLE 328 MARKETS ADJACENT TO PET BIOTICS MARKET 306 TABLE 329 PET SUPPLEMENTS MARKET, BY PET TYPE, 2021–2024 (USD MILLION) 307 TABLE 330 PET SUPPLEMENTS MARKET, BY PET TYPE, 2025–2030 (USD MILLION) 307 TABLE 331 PET FOOD INGREDIENTS MARKET, BY FORM, 2019–2022 (USD MILLION) 308 TABLE 332 PET FOOD INGREDIENTS MARKET, BY FORM, 2023–2028 (USD MILLION) 308 FIGURE 1 MARKET SCENARIO 34 FIGURE 2 GLOBAL PET BIOTICS MARKET, 2021-2030 35 FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PET BIOTICS MARKET (2020–2025) 35 FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF PET BIOTICS MARKET 36 FIGURE 5 HIGH-GROWTH SEGMENTS IN PET BIOTICS MARKET, 2025-2030 37 FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PET BIOTICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 38 FIGURE 7 RISING PET HUMANIZATION AND PREVENTIVE HEALTH FOCUS CREATE LUCRATIVE OPPORTUNITIES FOR MARKET PLAYERS 39 FIGURE 8 DOGS SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARES IN 2025 40 FIGURE 9 PROBIOTICS SEGMENT TO DOMINATE MARKET IN 2025 40 FIGURE 10 DOGS SEGMENT TO LEAD MARKET IN 2025 41 FIGURE 11 DRY FOOD SEGMENT TO DOMINATE MARKET IN 2025 41 FIGURE 12 DRY FORM TO DOMINATE MARKET IN 2025 41 FIGURE 13 US TO DOMINATE MARKET 42 FIGURE 14 PET BIOTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44 FIGURE 15 US: EXPENDITURE IN PET INDUSTRY, 2020–2024 (USD BILLION) 50 FIGURE 16 PET BIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 56 FIGURE 17 INGREDIENTS MOST FREQUENTLY PERCEIVED TO HAVE HEALTH BENEFITS 59 FIGURE 18 PERCENTAGE INCREASE YEAR OVER YEAR AND COMBINED NUMBER OF PETS IN US 60 FIGURE 20 PET BIOTICS MARKET: ECOSYSTEM ANALYSIS 64 FIGURE 21 AVERAGE SELLING PRICE OF KEY PLAYERS, BY APPLICATION, 2025 (USD) 65 FIGURE 22 AVERAGE SELLING PRICE TREND OF PET BIOTICS, BY REGION, 2021–2024 (USD/TON) 66 FIGURE 23 IMPORT OF HS CODE 3002, BY KEY COUNTRY, 2020–2024 (TONS) 67 FIGURE 24 EXPORT OF HS CODE 3002, BY KEY COUNTRY, 2020–2024 (TONS) 68 FIGURE 25 TRENDS/DISRUPTIONS INFLUENCING CUSTOMER BUSINESS 69 FIGURE 26 INVESTMENT AND FUNDING SCENARIO 70 FIGURE 29 FUTURE APPLICATIONS 83 FIGURE 31 PET BIOTICS MARKET DECISION-MAKING FACTORS 101 FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR THREE APPLICATIONS 102 FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 103 FIGURE 34 ADOPTION BARRIERS AND INTERNAL CHALLENGES 104 FIGURE 36 PET BIOTICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 140 FIGURE 37 PET BIOTICS MARKET, BY FORM, 2025 VS. 2030 (USD MILLION) 148 FIGURE 38 PET BIOTICS MARKET, BY PET, 2025 VS. 2030 (USD MILLION) 153 FIGURE 40 CHINA TO RECORD FASTEST GROWTH DURING FORECAST PERIOD 169 FIGURE 41 NORTH AMERICA: PET BIOTICS MARKET SNAPSHOT 172 FIGURE 42 ASIA PACIFIC: PET BIOTICS MARKET SNAPSHOT 193 FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD BILLION) 219 FIGURE 44 MARKET SHARE ANALYSIS, 2024 220 FIGURE 45 COMPANY VALUATION FOR MAJOR PLAYERS IN PET BIOTICS MARKET, 2025 222 FIGURE 46 EV/EBITDA OF MAJOR PLAYERS, 2025 222 FIGURE 47 PET BIOTICS MARKET: BRAND/PRODUCT COMPARISON 223 FIGURE 48 PET BIOTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 226 FIGURE 49 PET BIOTICS MARKET: COMPANY FOOTPRINT, 2024 227 FIGURE 50 PET BIOTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 232 FIGURE 51 ADM: COMPANY SNAPSHOT 240 FIGURE 52 KERRY GROUP PLC: COMPANY SNAPSHOT 247 FIGURE 53 INTERNATIONAL FLAVORS & FRAGRANCES INC: COMPANY SNAPSHOT 251 FIGURE 54 DSM-FIRMENICH: COMPANY SNAPSHOT 254 FIGURE 55 CARGILL, INCORPORATED: COMPANY SNAPSHOT 258 FIGURE 56 PROBI: COMPANY SNAPSHOT 263 FIGURE 57 INGREDION: COMPANY SNAPSHOT 266 FIGURE 58 PET BIOTICS MARKET: RESEARCH DESIGN 297 FIGURE 59 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION 299 FIGURE 60 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 301 FIGURE 61 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP 302 FIGURE 62 PET BIOTICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 303 FIGURE 63 DATA TRIANGULATION 304

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Pet Biotics Market By Type (Probiotics, Prebiotics, and Postbiotics), Application (Dry, Wet, Supplements, and Snacks & Treats), Pet (Dogs, Cats, and Other Pets), Form, Function, Manufacturing Technology, and Region – Global Forecast to 2030

授權報價

報告摘要

同分類最新報告（食品與飲料）